Get started
Author

Aymeric Ravel‐Chapuis

Observed names: A Ravel-Chapuis, AYMERIC RAVEL‐CHAPUIS, Aymeric Ravel-Chapuis, Aymeric Ravel-chapuis, RAVEL-CHAPUIS, Aymeric, Ravel-Chapuis, A.
Observed institutions: Lyon 1 Université, École Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, University of Ottawa, Université de Lyon, Laboratoire de Biologie et Modélisation de la Cellule, Institut National de la Recherche Agronomique, uOttawa Brain and Mind Research Institute
ORCID: 0000-0002-6965-7372
Observed ORCID: 0000-0002-6965-7372
OpenAlex ID: A5049198784
MUSK, a new target for mutations causing congenital myasthenic syndrome
2004 · Frédéric Chevessier, Brice Faraut, et al. · Human Molecular Genetics · 193
PDF
The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing
2012 · Aymeric Ravel-Chapuis, Guy Bélanger, et al. · The Journal of Cell Biology · 116
PDF
HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
2020 · Alexis Osseni, Aymeric Ravel-Chapuis, et al. · The Journal of Cell Biology · 59
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation
2022 · Alexis Osseni, Aymeric Ravel-Chapuis, et al. · Nature Communications · 47
PDF
Postsynaptic chromatin is under neural control at the neuromuscular junction
2007 · Aymeric Ravel‐Chapuis, Marie Vandromme, et al. · The EMBO Journal · 47
PDF
Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier
2016 · Emma Bondy-Chorney, Tara E. Crawford Parks, et al. · PLoS Genetics · 45
PDF
Synapse‐Specific Gene Expression at the Neuromuscular Junction
2003 · ALEXANDRE MÉJAT, AYMERIC RAVEL‐CHAPUIS, et al. · Annals of the New York Academy of Sciences · 39
Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression
2002 · Alban de Kerchove d'Exaerde, Jean Cartaud, et al. · EMBO Reports · 39
PDF
Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles
2018 · Aymeric Ravel-Chapuis, Ali Al-Rewashdy, et al. · Human Molecular Genetics · 37
Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin–NFAT signaling in skeletal muscle of DM1 mice
2017 · Aymeric Ravel-Chapuis, Guy Bélanger, et al. · Human Molecular Genetics · 35
PDF
The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc–dependent mechanism
2014 · Aymeric Ravel-Chapuis, Tara E. Crawford, et al. · Molecular Biology of the Cell · 35
Maintenance of CCL5 mRNA stores by post‐effector and memory CD8 T cells is dependent on transcription and is coupled to increased mRNA stability
2006 · Antoine Marçais, Martine Tomkowiak, et al. · European Journal of Immunology · 30
PDF
Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog
2017 · Tara E. Crawford Parks, Aymeric Ravel-Chapuis, et al. · Human Molecular Genetics · 29
PDF
Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients
2016 · Aymeric Ravel-Chapuis, Amanda Klein Gunnewiek, et al. · Molecular Biology of the Cell · 29
PAK1 and CtBP1 Regulate the Coupling of Neuronal Activity to Muscle Chromatin and Gene Expression
2015 · Jean-Luc Thomas, Vincent Moncollin, et al. · Molecular and Cellular Biology · 24
Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
2022 · Naomi S Misquitta, Aymeric Ravel-Chapuis, et al. · Human Molecular Genetics · 20
Pharmacological and exercise‐induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients
2022 · Aymeric Ravel‐Chapuis, Elise Duchesne, et al. · The Journal of Physiology · 19
Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events
2017 · Tara E. Crawford Parks, Kristen A. Marcellus, et al. · Scientific Reports · 18
PDF
Expression of Pannexin 1 and Pannexin 3 during skeletal muscle development, regeneration, and Duchenne muscular dystrophy
2018 · Tammy L. Pham, Marie‐Eve St‐Pierre, et al. · Journal of Cellular Physiology · 16
Differential regulation of autophagy by STAU1 in alveolar rhabdomyosarcoma and non‐transformed skeletal muscle cells
2021 · Shekoufeh Almasi, Tara E. Crawford Parks, et al. · Cellular Oncology · 15
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model
2023 · Nafisa Neault, Aymeric Ravel-Chapuis, et al. · International Journal of Molecular Sciences · 13
PDF
Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features
2020 · Tara E Crawford Parks, Kristen A Marcellus, et al. · Human Molecular Genetics · 12
PDF
Thrombin downregulates muscle acetylcholine receptors via an IP3 signaling pathway by activating its G‐protein‐coupled protease‐activated receptor‐1
2003 · Brice Faraut, Julien Barbier, et al. · Journal of Cellular Physiology · 11
PDF
Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK.
2005 · F Chevessier, B Faraut, et al. · PubMed · 10
Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I
2016 · Emma Bondy-Chorney, Tara E. Crawford Parks, et al. · Rare Diseases · 9
Works count: 49
Citation count: 1,015
H-index: 18
I10-index: 24
Year
Topic
Type